A Newly Identified Species Represents Its Own Eukaryotic Lineage

The 10-micrometer-long flagellate cell might have a big story to tell about the evolution of eukaryotes.

Written byKatarina Zimmer
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

A cross-section through the specialized organelle of Ancoracysta called the “ancoracyst,” which is hypothesized to function as a gun used to immobilize prey cellsDENIS TIKHONENKOV / RUSSIAN ACADEMY OF SCIENCESFrom an aquarium at the Scripps Institution of Oceanography in San Diego, California, scientists have identified a unicellular species that could shed light on how eukaryotes evolved, they report in Current Biology this week (November 22). The tiny organism—named Ancoracysta twista—is not only its own species, says lead author of the study, Jan Janouškovec, but “it represents a whole new lineage in the eukaryotic tree of life.”

A. twista is about 10 micrometers long and moves by using its whip-like flagellum. It is named after its distinguishing feature—the “ancoracyst,” a gun-like organelle that it uses to “shoot” at and immobilize its prey, usually other flagellate species. Janouškovec, a molecular biologist at University College London, along with an international team of scientists, discovered A. twista in a sample collected from the surface of a brain coral in a tropical aquarium.

The researchers realized that Ancoracysta represents its own lineage when phylogenetic models could not reconcile its genetic material with that of any existing lineages. Ancoracysta is a protist, a group of unicellular, eukaryotic organisms that sit at the root of the eukaryotic tree of life. For researchers such as Janouškovec, they are an ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • katya katarina zimmer

    After a year teaching an algorithm to differentiate between the echolocation calls of different bat species, Katarina decided she was simply too greedy to focus on one field of science and wanted to write about all of them. Following an internship with The Scientist in 2017, she’s been happily freelancing for a number of publications, covering everything from climate change to oncology. Katarina is a news correspondent for The Scientist and contributes occasional features to the magazine. Find her on Twitter @katarinazimmer and read her work on her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies